Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 9 studies | 29% ± 14% | |
| peripheral blood | 9 studies | 24% ± 7% | |
| kidney | 8 studies | 22% ± 2% | |
| brain | 7 studies | 36% ± 13% | |
| intestine | 4 studies | 20% ± 4% | |
| eye | 4 studies | 26% ± 9% | |
| uterus | 4 studies | 27% ± 16% | |
| bone marrow | 3 studies | 19% ± 4% | |
| breast | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 1861.55 | 258 / 258 | 100% | 72.68 | 230 / 230 |
| prostate | 100% | 1509.25 | 245 / 245 | 100% | 42.41 | 502 / 502 |
| brain | 100% | 1379.14 | 2640 / 2642 | 100% | 43.28 | 705 / 705 |
| thymus | 100% | 1853.95 | 653 / 653 | 100% | 64.66 | 604 / 605 |
| kidney | 100% | 1975.28 | 89 / 89 | 100% | 39.92 | 899 / 901 |
| ovary | 100% | 1384.96 | 180 / 180 | 100% | 74.88 | 428 / 430 |
| uterus | 100% | 1450.02 | 170 / 170 | 99% | 49.73 | 455 / 459 |
| skin | 100% | 1520.62 | 1808 / 1809 | 99% | 43.67 | 467 / 472 |
| breast | 100% | 1367.87 | 459 / 459 | 99% | 43.37 | 1104 / 1118 |
| bladder | 100% | 1427.48 | 21 / 21 | 98% | 57.70 | 496 / 504 |
| stomach | 100% | 922.96 | 359 / 359 | 98% | 35.00 | 281 / 286 |
| lung | 100% | 1492.48 | 578 / 578 | 98% | 38.78 | 1133 / 1155 |
| intestine | 100% | 1151.22 | 966 / 966 | 98% | 34.66 | 515 / 527 |
| esophagus | 100% | 1203.65 | 1445 / 1445 | 96% | 41.61 | 176 / 183 |
| pancreas | 96% | 468.31 | 315 / 328 | 99% | 47.98 | 177 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 53.06 | 29 / 29 |
| spleen | 100% | 1378.38 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 45.31 | 1 / 1 |
| blood vessel | 100% | 1971.37 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1275.78 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 895.28 | 853 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 35.85 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 32.52 | 44 / 45 |
| liver | 37% | 124.79 | 83 / 226 | 50% | 8.78 | 204 / 406 |
| peripheral blood | 86% | 828.03 | 797 / 929 | 0% | 0 | 0 / 0 |
| muscle | 72% | 283.75 | 581 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0010607 | Biological process | negative regulation of cytoplasmic mRNA processing body assembly |
| GO_0006397 | Biological process | mRNA processing |
| GO_0000956 | Biological process | nuclear-transcribed mRNA catabolic process |
| GO_0000932 | Cellular component | P-body |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NBDY |
| Protein name | Negative regulator of P-body association (P-body dissociating protein) (Protein NoBody) Negative regulator of P-body association Negative regulator of P-body association transcript variant 1 (Negative regulator of P-body association transcript variant 2) |
| Synonyms | LINC01420 |
| Description | FUNCTION: Promotes dispersal of P-body components and is likely to play a role in the mRNA decapping process. . |
| Accessions | A0A0U1RRE5 A0A4P8PLQ7 ENST00000637096.1 A0A0U1RR68 ENST00000451583.1 ENST00000374922.9 ENST00000423617.2 |